In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | S-1/A |
Revenues: |
Product Sales and Services | | | 44.2 | 47.3 | 18.0 | |
Technology Licensing | | | 4.7 | 3.6 | | |
Technology Development | | | 5.1 | 3.2 | 0.5 | |
Total revenues [+] | 38.6 | 35.9 | 54.0 | 54.0 | 18.6 | 27.4 |
Licensing | | 0.4 | 4.7 | 3.6 | | |
Products | 33.0 | 29.4 | 40.4 | 44.9 | 17.1 | 16.5 |
Services | 5.6 | 4.9 | 3.8 | 2.3 | 0.9 | 0.9 |
Technology services | | 1.2 | 5.1 | 3.2 | 0.5 | |
Revenue growth [+] | 7.4% | -33.5% | 0.0% | 191.0% | -32.2% | |
Product Sales and Services | | | -6.6% | 161.9% | | |
Technology Licensing | | | 32.3% | | | |
Technology Development | | | 60.6% | 509.6% | | |
Cost of goods sold [+] | 30.9 | 33.1 | 43.8 | 43.8 | 17.8 | 16.0 |
Cost of product sales | 27.5 | 29.2 | 38.5 | 39.1 | 14.8 | |
Cost of services | 3.4 | 3.9 | 5.3 | 4.7 | 3.0 | |
Gross profit | 7.7 | 2.8 | 10.2 | 10.2 | 0.8 | 11.4 |
Gross margin | 19.9% | 7.9% | 18.9% | 18.9% | 4.3% | 41.7% |
Selling, general and administrative [+] | 6.6 | 9.8 | 12.7 | 13.0 | 9.9 | 10.0 |
Sales and marketing | 2.6 | 3.5 | 4.2 | 3.9 | 3.0 | 2.9 |
General and administrative | 4.0 | 6.4 | 8.5 | 9.0 | 6.9 | 7.1 |
Research and development | 1.9 | 2.6 | 3.4 | 4.8 | 4.2 | 4.3 |
Other operating expenses | -1.5 | -1.0 | | | | 4.7 |
EBITDA [+] | 1.2 | -7.9 | -5.1 | -6.5 | -12.4 | |
EBITDA growth | -114.7% | 56.1% | -22.0% | -47.2% | 64.7% | |
EBITDA margin | 3.0% | -22.1% | -9.4% | -12.1% | -66.6% | -27.4% |
Depreciation | 0.5 | 0.5 | 0.6 | 0.8 | 0.8 | |
EBITA | 0.7 | -8.5 | -5.7 | -7.3 | -13.2 | -7.5 |
EBITA margin | 1.7% | -23.6% | -10.5% | -13.5% | -70.9% | -27.4% |
Amortization of intangibles | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | |
EBIT [+] | 0.6 | -8.6 | -5.9 | -7.5 | -13.4 | -7.5 |
EBIT growth | -107.5% | 46.4% | -21.3% | -44.1% | 77.8% | |
EBIT margin | 1.7% | -24.0% | -10.9% | -13.8% | -71.9% | -27.4% |
Non-recurring items [+] | | 0.4 | | | 0.8 | 2.1 |
Asset impairment | | 0.4 | | | | |
Loss (gain) on sale of assets | | | | | 0.8 | |
Interest expense | 0.1 | 0.1 | 0.2 | 0.3 | 0.5 | 0.1 |
Interest expense | 0.1 | 0.1 | 0.2 | 0.3 | 0.5 | 0.1 |
Other income (expense), net [+] | -0.5 | 0.3 | -0.2 | 0.0 | 0.2 | 4.5 |
Gain (loss) on sale of assets | -1.5 | -1.0 | | | | |
Change in fair value of warrants | | | | | 0.2 | |
Other | -0.5 | 0.3 | -0.2 | 0.0 | | |
Pre-tax income | 0.1 | -8.8 | -6.2 | -7.8 | -14.5 | -5.2 |
Income taxes | 0.0 | 0.2 | 1.6 | 1.0 | 0.0 | 1.0 |
Tax rate | 13.2% | | | | | |
Net income | 0.1 | -8.9 | -7.8 | -8.8 | -18.3 | 0.0 |
Net margin | 0.2% | -24.9% | -14.4% | -16.3% | -98.3% | 0.0% |
|
Basic EPS [+] | $0.00 | ($0.39) | ($0.34) | ($0.44) | ($4.71) | ($821.92) |
Growth | -100.6% | 13.1% | -22.8% | -90.6% | -99.4% | |
Diluted EPS [+] | $0.00 | ($0.39) | ($0.34) | ($0.44) | ($4.71) | ($821.92) |
Growth | -100.6% | 13.1% | -22.8% | -90.6% | -99.4% | |
|
Shares outstanding (basic) [+] | 23.7 | 23.2 | 22.9 | 19.9 | 3.9 | 0.0 |
Growth | 2.1% | 1.5% | 15.0% | 413.4% | 25695859.4% | |
Shares outstanding (diluted) [+] | 23.7 | 23.2 | 22.9 | 19.9 | 3.9 | 0.0 |
Growth | 2.1% | 1.5% | 15.0% | 413.4% | 25695859.4% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |